2014
DOI: 10.3844/ajassp.2014.273.279
|View full text |Cite
|
Sign up to set email alerts
|

Caring More by Doing Less? An Enquiry About the Impacts of Outsourcing on Patient Care

Abstract: This study seeks to understand the potential impact of outsourcing on healthcare processes. By referring to a wider scope of industries and sectors, as they have been the experimental fields of most of the studies on outsourcing, we highlight the pros and cons of the externalization of activities related to patient care. Our purpose is to show and contextualize the (yet) ambiguous effects of relying on external partners in delivering services related to the health of patients. We argue that the seek for effici… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 42 publications
(45 reference statements)
0
3
0
Order By: Relevance
“…Previous studies have analyzed the healthcare, pharmaceutical and biotechnology industry under a number of different perspectives, such as innovation propensity and firm profitability (Roberts, 2001;Lee et al, 2008), inter-organizational collaboration and learning effects (Powell et al, 1996;2005;D'Alise et al, 2010;Brunetta et al, 2012), vertical integration and collaborative agreements (Pisano, 1990;1991, Suresh andAlli, 2012), outsourcing Brunetta et al, 2014;Marchegiani et al, 2013;Brunetta and Marchegiani, 2009), alliance formation (Baum et al, 2000) and network perspectives (Powell et al, 1996;2005;Gulati and Singh, 1996). Firms in this industry are "multivocal" and commonly perform different activities with a diverse set of partners (Powell et al, 2005).…”
Section: Resultsmentioning
confidence: 99%
“…Previous studies have analyzed the healthcare, pharmaceutical and biotechnology industry under a number of different perspectives, such as innovation propensity and firm profitability (Roberts, 2001;Lee et al, 2008), inter-organizational collaboration and learning effects (Powell et al, 1996;2005;D'Alise et al, 2010;Brunetta et al, 2012), vertical integration and collaborative agreements (Pisano, 1990;1991, Suresh andAlli, 2012), outsourcing Brunetta et al, 2014;Marchegiani et al, 2013;Brunetta and Marchegiani, 2009), alliance formation (Baum et al, 2000) and network perspectives (Powell et al, 1996;2005;Gulati and Singh, 1996). Firms in this industry are "multivocal" and commonly perform different activities with a diverse set of partners (Powell et al, 2005).…”
Section: Resultsmentioning
confidence: 99%
“…Consequently, several dedicated productive structuresfor example patent-protected drugs -are losing their sheen as branded drugs lose their patent exclusivity and face increasing competition from generics. So far, literature has widely analysed the pharmaceutical and biotechnology industry under a number of different perspectives, such as the resource-based view [1][2], the knowledge-based view [3][4][5], strategic groups formation [6][7][8], innovation propensity and firm profitability (recent studies have empirically tested the influence of a group of innovation related variables on company performance, with findings suggesting a positive relationship between the two) [9][10][11][12], inter-organizational collaboration and learning effects [13][14][15][16], vertical integration and collaborative agreements [3][4], outsourcing [17][18][19], alliance formation [20] and network perspectives [13][14][15]21]. The pharmaceutical industry has, indeed, seen a deep transformation in recent years; in terms of the geographical concentration of the R&D and commercial activities, increased regulatory controls and technological complexity and expanding disease targets and cost containment policies.…”
Section: Introductionmentioning
confidence: 99%
“…In particular, there are few studies that focus on all the significant system elements and relationships between them (Bhakoo et al, 2012;Rich and Piercy, 2013). Among the relevant literature, a number of works (Nicholson et al, 2004;Pan and Pokharel, 2007) have addressed the benefits and limitations of logistics outsourcing in HC organizations as a way of achieving efficiency by focusing internal resources on core processes (Brunetta et al, 2014). Another topic well debated in literature is inventory management due to its relevance in HC logistics dealing hospitals with large amounts of a great variety of products and carrying inventory costs ranging from 10 to 18% of the net revenue (De Vries, 2011).…”
Section: Introductionmentioning
confidence: 99%